NCT05722392 Safety and Efficacy of Two-step Radical Prostatectomy
| NCT ID | NCT05722392 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sun Yat-sen University |
| Condition | Prostate Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-02-15 |
| Primary Completion | 2033-02-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2023-02-15 with a primary completion date of 2033-02-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about the safety and efficacy of two-step radical prostatectomy in the treatment of low- to intermediate-risk prostate cancer patient with enlarged prostate and severe benign prostatic hyperplasia. The main question it aims to answer are: 1. Whether two-step prostatectomy is safe enough to decrease the surgical difficulty of these patients? 2. Whether the oncologic control is promising?
Eligibility Criteria
Inclusion Criteria: 1. Diagnosed as prostate cancer pathologically by prostate biopsy 2. Evaluated as localized prostate cancer by imaging studies 3. Prostate volume\>70mL evaluated by transrectal ultrasonography or multi-parametric magnetic resonance imaging 4. Gleason score≤ 4+3=7 5. Preoperative PSA\<20ng/mL 6. Estimated survival\> 10 years； 7. Informed consent is obtained from the patient Exclusion Criteria: 1. The patient has received other therapy including radical radiotherapy, transurethral resection of the prostate, cryoablation, HIFU, etc. 2. Any contraindication of surgery or anaesthesia
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05722392 clinical trial?
This trial is open to male participants only, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05722392 currently recruiting?
Yes, NCT05722392 is actively recruiting participants. Contact the research team at liyongh@sysucc.org.cn for enrollment information.
Where is the NCT05722392 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT05722392 clinical trial?
NCT05722392 is sponsored by Sun Yat-sen University. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.